(ENB) Enbridge - Overview
Stock: Pipelines, Gas Transmission, Gas Distribution, Renewable Energy
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.92% |
| Yield on Cost 5y | 13.97% |
| Yield CAGR 5y | 0.24% |
| Payout Consistency | 96.9% |
| Payout Ratio | 94.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 16.0% |
| Relative Tail Risk | 4.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.81 |
| Alpha | 11.12 |
| Character TTM | |
|---|---|
| Beta | 0.183 |
| Beta Downside | 0.195 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.23% |
| CAGR/Max DD | 0.73 |
Description: ENB Enbridge January 27, 2026
Enbridge Inc. (NYSE: ENB) is a North-American energy-infrastructure firm organized into four operating segments: Liquids Pipelines, which moves crude oil and refined products across Canada and the U.S.; Gas Transmission & Midstream, which owns and expands natural-gas pipelines and processing facilities; Gas Distribution & Storage, which supplies residential, commercial and industrial gas customers in Ontario and Quebec; and Renewable Power Generation, which develops wind, solar, geothermal, waste-heat and transmission assets.
Key recent metrics (Q3 2024 data) illustrate the company’s current positioning: the Liquids Pipelines segment reported an 84 % utilization rate and generated $13.5 billion in adjusted EBITDA for 2023, while the Gas Transmission segment benefited from a 12 % rise in average natural-gas price to $2.70 /MMBtu, supporting a 7 % YoY increase in segment earnings. Enbridge’s renewable portfolio now totals roughly 2.5 GW of operating capacity, contributing about 2 % of total revenue, with a target to double that capacity by 2028. The firm continues to pay a dividend yielding ~7.5 % and has a credit rating of A- (S&P), reflecting its cash-flow stability but also its exposure to regulatory risk on pipeline expansions.
For a deeper quantitative breakdown of ENB’s risk-adjusted returns, the ValueRay platform offers a concise dashboard worth a look.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 6.03b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.02 > 1.0 |
| NWC/Revenue: -3.31% < 20% (prev -14.74%; Δ 11.43% < -1%) |
| CFO/TA 0.08 > 3% & CFO 12.12b > Net Income 6.03b |
| Net Debt (73.38b) to EBITDA (18.64b): 3.94 < 3 |
| Current Ratio: 0.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.19b) vs 12m ago 0.28% < -2% |
| Gross Margin: 35.13% > 18% (prev 0.38%; Δ 3474 % > 0.5%) |
| Asset Turnover: 35.53% > 50% (prev 23.60%; Δ 11.94% > 0%) |
| Interest Coverage Ratio: 2.68 > 6 (EBITDA TTM 18.64b / Interest Expense TTM 4.88b) |
Altman Z'' 0.52
| A: -0.01 (Total Current Assets 8.67b - Total Current Liabilities 10.80b) / Total Assets 155.79b |
| B: -0.09 (Retained Earnings -13.69b / Total Assets 155.79b) |
| C: 0.07 (EBIT TTM 13.06b / Avg Total Assets 180.78b) |
| D: 0.39 (Book Value of Equity 41.73b / Total Liabilities 106.38b) |
| Altman-Z'' Score: 0.52 = B |
Beneish M -3.10
| DSRI: 0.57 (Receivables 4.27b/5.67b, Revenue 64.23b/48.55b) |
| GMI: 1.09 (GM 35.13% / 38.45%) |
| AQI: 1.01 (AQ_t 0.34 / AQ_t-1 0.34) |
| SGI: 1.32 (Revenue 64.23b / 48.55b) |
| TATA: -0.04 (NI 6.03b - CFO 12.12b) / TA 155.79b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of ENB shares?
Over the past week, the price has changed by +3.71%, over one month by +3.16%, over three months by +7.00% and over the past year by +17.95%.
Is ENB a buy, sell or hold?
- StrongBuy: 8
- Buy: 2
- Hold: 11
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the ENB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 57 | 15.7% |
| Analysts Target Price | 57 | 15.7% |
| ValueRay Target Price | 58.3 | 18.4% |
ENB Fundamental Data Overview January 29, 2026
P/E Trailing = 26.1075
P/E Forward = 21.097
P/S = 1.6503
P/B = 2.4631
P/EG = 1.8363
Revenue TTM = 64.23b CAD
EBIT TTM = 13.06b CAD
EBITDA TTM = 18.64b CAD
Long Term Debt = 100.60b CAD (from longTermDebt, last quarter)
Short Term Debt = 2.23b CAD (from shortTermDebt, last quarter)
Debt = 74.46b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 73.38b CAD (from netDebt column, last quarter)
Enterprise Value = 216.45b CAD (143.39b + Debt 74.46b - CCE 1.41b)
Interest Coverage Ratio = 2.68 (Ebit TTM 13.06b / Interest Expense TTM 4.88b)
EV/FCF = 52.84x (Enterprise Value 216.45b / FCF TTM 4.10b)
FCF Yield = 1.89% (FCF TTM 4.10b / Enterprise Value 216.45b)
FCF Margin = 6.38% (FCF TTM 4.10b / Revenue TTM 64.23b)
Net Margin = 9.38% (Net Income TTM 6.03b / Revenue TTM 64.23b)
Gross Margin = 35.13% ((Revenue TTM 64.23b - Cost of Revenue TTM 41.67b) / Revenue TTM)
Gross Margin QoQ = 42.02% (prev 33.13%)
Tobins Q-Ratio = 1.39 (Enterprise Value 216.45b / Total Assets 155.79b)
Interest Expense / Debt = 1.69% (Interest Expense 1.26b / Debt 74.46b)
Taxrate = 27.17% (316.0m / 1.16b)
NOPAT = 9.51b (EBIT 13.06b * (1 - 27.17%))
Current Ratio = 0.80 (Total Current Assets 8.67b / Total Current Liabilities 10.80b)
Debt / Equity = 1.59 (Debt 74.46b / totalStockholderEquity, last quarter 46.80b)
Debt / EBITDA = 3.94 (Net Debt 73.38b / EBITDA 18.64b)
Debt / FCF = 17.91 (Net Debt 73.38b / FCF TTM 4.10b)
Total Stockholder Equity = 61.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.33% (Net Income 6.03b / Total Assets 155.79b)
RoE = 9.78% (Net Income TTM 6.03b / Total Stockholder Equity 61.60b)
RoCE = 8.05% (EBIT 13.06b / Capital Employed (Equity 61.60b + L.T.Debt 100.60b))
RoIC = 5.88% (NOPAT 9.51b / Invested Capital 161.77b)
WACC = 4.76% (E(143.39b)/V(217.86b) * Re(6.59%) + D(74.46b)/V(217.86b) * Rd(1.69%) * (1-Tc(0.27)))
Discount Rate = 6.59% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 1.43%
[DCF Debug] Terminal Value 87.27% ; FCFF base≈5.46b ; Y1≈6.04b ; Y5≈7.80b
Fair Price DCF = 71.78 (EV 230.07b - Net Debt 73.38b = Equity 156.70b / Shares 2.18b; r=5.90% [WACC]; 5y FCF grow 12.03% → 2.90% )
EPS Correlation: -42.36 | EPS CAGR: -50.27% | SUE: -4.0 | # QB: 0
Revenue Correlation: 38.14 | Revenue CAGR: 4.26% | SUE: 0.77 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.94 | Chg30d=-0.008 | Revisions Net=-2 | Analysts=4
EPS next Year (2026-12-31): EPS=3.07 | Chg30d=+0.002 | Revisions Net=-3 | Growth EPS=+4.5% | Growth Revenue=-4.3%